TTR and early-onset autosomal dominant Alzheimer disease: This may account for TTR's ability to suppress neuropathological and behavioral manifestations in transgenic models of human Alzheimer's disease (AD).30–33In vitro TTR inhibits Aβ aggregation by two distinct mechanisms.